News

CorVista Health is Hiring Chief of Staff

This role is an integral part of the growth and success of a dynamic, fast paced startup at the cusp of commercialization.  We seek a strong Chief of Staff who will work closely with the CEO on execution of all projects associated with the success of the company, from administrative to HR support, stakeholder communications, and beyond.  We seek a professional with a “can do” attitude who is detail-oriented, resourceful, organized and holds a high degree of professionalism.

THE ROLE

RESPONSIBILITIES

  • Provide high-level administrative support to the CEO and leadership team who move fast and are building a rapidly growing Health technology company
  • Improve current processes and coordinate organizational procedures for optimized efficiency and productivity
  • Project manager on new facility in Washington, DC
  • Maintains executive appointment schedule by planning and scheduling meetings, conferences, and travel
  • Manages and maintains executive calendar
  • Tracks and prioritizes projects perform supporting research and effectively communicates within the organization
  • Execute special or continuous research and data analysis. Analyzes problems, determines approach, compiles and analyzes data, and prepares reports / recommendations for action by a management team.
  • Assist in HR-related activities; work with our consultant in establishing formal processes and procedures
  • Manage and gathering of confidential onboarding documentation checklists/procedures
  • Manage confidential termination checklists/procedures
  • Assist/lead board-related communications/activities, board meetings
  • Assist/administer shareholder communications program, shareholder meetings, etc.
  • Maintain equity documents in CARTA system
  • Assist/administer public relations/corporate communications activities
  • Assist/administer communications program with strategics, bankers, etc.
  • Assist/administer contracts management and some negotiations
  • Provide support in JLabs office

 

QUALIFICATIONS

  • Demonstrated competency in project management
  • Entrepreneurial and willingness to “roll up sleeves”
  • Be extremely computer savvy
  • Have excellent written and verbal communication skills
  • Be flexible and take initiative on projects
  • Have outgoing and creative personality
  • Be able to multi-task and work on several projects at once
  • Have a desire to get involved and understand the needs of a growing business
  • Have basic experience with social media
  • Possesses excellent communication skills; both written and verbal
  • Problem Solver – Quantitative Aptitude, Logical Reasoning
  • Experience creating systems, processes and procedures- Abstract Reasoning
  • Detail-oriented, organized, and self-starting
  • Bachelor’s degree required
  • Commutable distance to Washington DC

To Apply: https://careers.mullingsgroup.com/position/corvista-chief-of-staff/

Recent News

10/21/2025

SRI multi-party team selected as an awardee by ARPA-H to develop at-home screening for ≥30 types of cancers

SRI, along with research partners Foothold Labs and Triple Ring Technologies and commercial partner Beacon Dx Health, has been awarded up to $34 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop technology as part of the POSEIDON (Platform Optimizing SynBio for Early Intervention and Detection in Oncology) program. This pioneering program

10/21/2025

Quoin Pharmaceuticals Announces U.S. FDA Grants Orphan Drug Designation for QRX003 in Netherton Syndrome

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead product candidate, QRX003, for the treatment of Netherton Syndrome. The designation follows previously granted Orphan

10/20/2025

Merck Breaks Ground on $3 Billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the start of construction for a $3 billion, 400,000-square-foot pharmaceutical manufacturing facility at its Elkton, Virginia, site. Merck’s investment in the Center of Excellence for Pharmaceutical Manufacturing is part of a more than $70 billion investment beginning in 2025 to